LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA (CML) - ARE THERE ANY PROGNOSTIC FACTORS

被引：0
|
作者：
PRISCHL, F
SCHWARZMEIER, J
HAAS, O
GRANINGER, W
机构：
[1] VIENNA UNIV,MED CLIN 1,A-1010 VIENNA,AUSTRIA
[2] VIENNA UNIV,CHEMOTHERAPY CLIN,A-1010 VIENNA,AUSTRIA
[3] ST ANNA CHILDRENS HOSP,VIENNA,AUSTRIA
来源：
BLUT | 1984年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [1] PARAMETERS INDICATIVE OF FAVORABLE PROGNOSIS IN LONG-TERM SURVIVAL OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
    PRISCHL, FC
    HAAS, OA
    LION, T
    SCHWARZMEIER, JD
    BLUT, 1988, 57 (04): : 209 - 209
  • [2] PROGNOSTIC FACTORS IN DIFFERENT STAGES OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, HM
    LEUKEMIA, 1987, 1 (03) : 255 - 255
  • [3] SPLENECTOMY IN CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS - LONG-TERM FOLLOW UP
    HESTER, J
    MCBRIDE, CM
    MCCREDIE, KB
    FREIREICH, EJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 : 66 - 66
  • [4] A RETROSPECTIVE STUDY OF PROGNOSTIC FACTORS AT DIAGNOSIS IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    ZALOZNIK, AJ
    DIBELLA, NJ
    BOURG, WC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 478 - 478
  • [5] LONG-TERM SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA COMPLICATED BY CHRONIC ACTIVE HEPATITIS
    ROTOLI, B
    FORMISANO, S
    MARTINELLI, V
    NIGRO, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27): : 1712 - 1713
  • [6] PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY AND SURVIVAL IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN BLASTIC CRISIS (CML-BC)
    KANTARJIAN, H
    WALTERS, R
    KEATING, M
    TALPAZ, M
    MCCREDIE, K
    FREIREICH, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 194 - 194
  • [7] PROGNOSTIC FACTORS IN ACUTE-LEUKEMIA WITH LONG-TERM SURVIVAL (LTS)
    PAVLOVSKY, S
    MURIEL, FS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 345 - 345
  • [8] PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL WITH ALPHA-INTERFERON (IFN-A) THERAPY IN EARLY CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, H
    SMITH, T
    OBRIEN, S
    ROBERTSON, L
    KOLLER, C
    BERAN, M
    KEATING, M
    TALPAZ, M
    BLOOD, 1993, 82 (10) : A378 - A378
  • [9] Gender specific issues in chronic myelogenous leukemia (CML): Long-term results from randomized trials.
    Berger, U
    Hochhaus, A
    Reiter, A
    Pfirrmann, M
    Maywald, O
    Lahaye, T
    Hasford, J
    Heimpel, H
    Hossfeld, DK
    Kolb, HJ
    Loeffler, H
    Pralle, H
    Queisser, W
    Hehlmann, R
    BLOOD, 2003, 102 (11) : 905A - 905A
  • [10] Detection of bcr/abl mRNA in a case of chronic myelogenous leukemia in long-term remission:: CML or sensitivity of detection?
    Anguita, E
    Villegas, A
    Díaz-Mediavilla, J
    González, FA
    Del Potro, E
    Espinós, D
    HAEMATOLOGICA, 1998, 83 (08) : 744 - 747
12345